California's affordability office last year set a five-year target to cap statewide spending growth, starting at 3.5% in 2025 ...
President Donald Trump's signature domestic policy bill, passed this summer, will cost Baystate Health $146.7 million a year, its president and CEO told business leaders Monday. Peter D. Banko called ...
The U.S. faces a critical deadline in January 2026 to prove it has stopped measles transmission and could lose its elimination status if large outbreaks linked to ongoing cases (like those from the ...
FDA Commissioner Martin Makary said the government must show greater humility and be more transparent if it hopes to rebuild public trust in its health guidance, which he said has been badly eroded ...
Paxlovid, an FDA-approved oral antiviral pill that can be taken at home, is the go-to treatment for COVID-19. If you are at high risk for severe disease from COVID, and you take it as soon as possible ...
Speaker Mike Johnson is barreling toward a Wednesday vote on a healthcare bill he and other Republican leaders are presenting as an alternative to the tax credits that are set to expire at the end of ...
Pittsburgh-based Highmark Inc. this week unveiled its new collaboration with Blue Cross and Blue Shield of Kansas City (Blue KC), a move that company officials said will reinforce their commitment to ...
Highmark Health took a $69 million net loss in the first nine months of the year as the Pittsburgh-based company struggled with more frequent and costly health insurance claims. The organization's ...
A molecule involved in red blood cell production determines whether the immune system attacks or ignores cells in the body via peripheral immune tolerance, Stanford Medicine researchers find.
In the field of infectious diseases, rapid and precise diagnosis is important to ensure not only timely treatment, but effective surveillance as well.
A bipartisan group of senators is making a renewed push toward finding a healthcare solution as the hour-glass winds down to the end-of-month deadline to extend the enhanced Affordable Care Act ...
New research estimates the financial consequences of the bill for hospitals and health systems in 2026 and 2027 as a result of coverage and payer mix changes.